Platform Specialty Products (PAH) Tops Q3 EPS by 1c, Revenues Miss; Affirms FY18 Adj. EBITDA Outlook

Go back to Platform Specialty Products (PAH) Tops Q3 EPS by 1c, Revenues Miss; Affirms FY18 Adj. EBITDA Outlook

Platform Specialty Products Corporation Announces Third Quarter 2018 Financial Results

November 1, 2018 6:55 AM EDT

Net sales from continuing operations increased 2% on a reported basis to $489 million; growth of 3% on an organic basisGAAP diluted loss per share from continuing operations of $0.02; adjusted earnings per share from continuing operations of $0.04Reported net loss from continuing operations of $4.3 million; improved from a loss of $36.9 million in the same period last yearAdjusted EBITDA from continuing operations grew 1% to $108 million; growth of 3% on a constant currency basisReaffirming 2018 adjusted EBITDA guidance, excluding discontinued operations (Arysta LifeScience), expected to be in the range of $425 million to $445... More